biologic

Yf-Vax

Yellow Fever Vaccine

Loss of exclusivityDecember 2011projected — 12-year biologic exclusivity estimate
CompanySanofi Vaccines US Inc.

Drug detail

Brand nameYf-Vax
Active ingredientYellow Fever Vaccine
Strength4.74PFU/.5ML
Dosage formFor Injection
RouteSubcutaneous
ModalityBiologic
FDA approvalDecember 1999
Marketing statusRx

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Yf-Vax patent cliff — loss of exclusivity December 2011 | CliffBio